Skip to content

Internet-delivered Psychodynamic Therapy for Depression

Internet-delivered Psychodynamic Therapy for Depression: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01324050
Enrollment
92
Registered
2011-03-28
Start date
2011-02-28
Completion date
2011-05-31
Last updated
2011-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with mild to moderate major depression and compare its efficacy to an active control group.

Interventions

BEHAVIORALInternet-delivered psychodynamic therapy for depression

This intervention contains 9 text-based self-help modules. These modules contain material inspired by psychoanalytic theory about identifying reoccurring patterns in life among other things. In addition to the self-help modules, 10-15 minutes of therapist contact is given every week. In total, the intervention will last for 10 weeks.

BEHAVIORALInternet-delivered therapist support

This intervention contains 1 text-based self-help module, which is mainly based on information on depression. In addition to this text, the participants in this group gets 10-15 minutes of therapist contact every week. In the conversation with the therapist, the participant informs the therapist about the activities during the week. This intervention is considered to be a form of support. In total, the intervention will last for 10 weeks.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Major Depressive Disorder * 15 or more on MADRS-S

Exclusion criteria

* Severe depression (more than 35 on MADRS-S or based on interview) * Severe psychiatric condition (e.g. psychosis or bipolar disorder) * Suicidal (measured in diagnostic interview) * Changed medication during the last three months

Design outcomes

Primary

MeasureTime frame
Beck Depression Inventory (BDI)Two weeks before the treatment starts

Secondary

MeasureTime frame
Quality of Life Inventory (QOLI)Two weeks before treatment starts
Patient Health Questionnaire 9 (PHQ-9)Two weeks before treatment starts
Generalised Anxiety Disorder Assessment 7 (GAD-7)Two weeks before treatment starts
Beck Anxiety Inventory (BAI)Two weeks before the treatment starts
Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S)Two weeks before treatment starts

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026